DDO1002, an NRF2-KEAP1 inhibitor, improves hematopoietic stem cell aging and stress response.
Li Y, Wu A, Jin X, Shen H, Zhao C, Yi X, Nie H, Wang M, Yin S, Zuo H, Ju Z, Jiang Z, Wang H.
Li Y, et al. Among authors: yi x.
Life Med. 2024 Dec 12;3(6):lnae043. doi: 10.1093/lifemedi/lnae043. eCollection 2024 Dec.
Life Med. 2024.
PMID: 39872153
Free PMC article.